See more : Quantum Build-Tech Limited (QUANTBUILD.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Redwood Pharma AB (REDW.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Redwood Pharma AB, a leading company in the Biotechnology industry within the Healthcare sector.
- Shenzhen Fine Made Electronics Group Co., Ltd. (300671.SZ) Income Statement Analysis – Financial Results
- Interroll Holding AG (IRRHF) Income Statement Analysis – Financial Results
- Jensen-Group NV (JEN.BR) Income Statement Analysis – Financial Results
- Victory Giant Technology (HuiZhou)Co.,Ltd. (300476.SZ) Income Statement Analysis – Financial Results
- Jinghua Pharmaceutical Group Co., Ltd. (002349.SZ) Income Statement Analysis – Financial Results
Redwood Pharma AB (REDW.ST)
About Redwood Pharma AB
Redwood Pharma AB engages in the development of ophthalmic pharmaceutical therapies for unmet market needs. The company's lead development product is RP101, an eye drop that treats severe chronic dry eye disease in post-menopausal women. It uses IntelliGel, a supramolecular smart drug delivery system for development of topical formulation for ophthalmic uses, as well as for administration to the front of the eye. Redwood Pharma AB is based in Stockholm, Sweden.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 720.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -720.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 7.86K | 6.67K | 13.58K | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 11.25M | 12.32M | 11.96M | 18.18M | 7.77M | 165.48K | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 12.28K | 13.06M | 20.49M | 11.25M | 12.32M | 11.96M | 18.18M | 7.77M | 165.48K | 219.60 |
| Other Expenses | 0.00 | 13.05M | 20.48M | 3.27M | 3.19M | 2.01M | 1.03M | 967.70K | 28.00 | 0.00 |
| Operating Expenses | 12.79K | 13.05M | 20.48M | 14.52M | 15.51M | 13.97M | 19.22M | 8.74M | 165.51K | 88.03 |
| Cost & Expenses | 13.51K | 13.05M | 20.48M | 14.52M | 15.51M | 13.97M | 19.22M | 8.74M | 165.51K | 88.03 |
| Interest Income | 675.75 | 8.48K | 360.60 | 2.51 | 245.75 | 0.00 | 34.00 | 356.00 | 5.00 | 0.02 |
| Interest Expense | 746.40K | 48.00 | 360.60K | 2.51K | 245.75K | 6.00 | 0.00 | 99.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 544.84 | 13.05K | 20.48K | 14.52K | 15.51K | 13.97K | 19.22K | 8.74K | 5.00 | -94.95 |
| EBITDA | -12.96K | -13.04M | -20.48M | -14.52M | -15.51M | -13.97M | -19.22M | -8.74M | 7.74K | -6.90 |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -13.51K | -13.05M | -20.48M | -14.52M | -15.51M | -13.97M | -19.22M | -8.74M | -165.51K | 94.95 |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -675.75 | 8.43K | -360.60K | -2.51K | -245.75K | -6.00 | 34.00 | 257.00 | 7.74K | -6.90 |
| Income Before Tax | -14.18K | -13.04M | -20.84M | -14.53M | -15.76M | -13.97M | -19.22M | -8.74M | -157.77K | 88.05 |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -8.48K | 360.60K | 2.51K | 245.75K | -161.14K | -19.18K | -8.38K | 0.00 | 5.10 |
| Net Income | -14.18K | -13.03M | -21.20M | -14.53M | -16.00M | -13.97M | -19.22M | -8.74M | -157.77K | 82.95 |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -5.35 | -28.31 | -31.97 | -28.88 | -32.41 | -0.35 | -0.68 | -0.51 | -0.01 | 0.00 |
| EPS Diluted | -5.34 | -28.31 | -31.97 | -28.88 | -32.41 | -0.35 | -0.68 | -0.51 | -0.01 | 0.00 |
| Weighted Avg Shares Out | 2.65K | 460.36K | 663.09K | 503.00K | 493.73K | 39.61M | 28.13M | 17.28M | 17.28M | 0.00 |
| Weighted Avg Shares Out (Dil) | 2.65K | 460.36K | 663.09K | 503.00K | 493.73K | 39.61M | 28.13M | 17.28M | 17.28M | 0.00 |
Source: https://incomestatements.info
Category: Stock Reports